| ''Hot''unstable angina-Is it worse than subacute unstable angina? Results from the GUARANTEE registry CP Cannon, JJ Ferguson, N Every, HV Anderson, FV Aguirre, CB Granger, ... JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29 (2), 78103-78103, 1997 | | 1997 |
| “Hot” unstable angina—is it worse than subacute unstable angina? Results from the GUARANTEE registry NK Sekaran BS, DJ Moliterno, JJ Ferguson, N Every, HV Anderson, ... Journal of thrombosis and thrombolysis 12, 207-216, 2001 | 1 | 2001 |
| “Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure DE Forman, CP Cannon, AF Hernandez, L Liang, C Yancy | | 2008 |
| 1006-42 What Beyond Aspirin and Anticoagulation Improves Outcome in Unstable Angina? Effect of Medical Therapy S Borzak, PL Kraft, L Douthat, CP Cannon, E Antman, J Massaro, ... Journal of the American College of Cardiology 25 (2), 356A, 1995 | | 1995 |
| 1021-101 Association of glomerular filtration rate on presentation with subsequent mortality in non-ST elevation acute coronary syndromes R Dumaine, CM Gibson, DS Pinto, SA Murphy, DA Morrow, HP Hobbach, ... Journal of the American College of Cardiology 43 (5S1), A250-A250, 2004 | | 2004 |
| 1021-102 Underachievement of low-density lipoprotein cholesterol goal in patients on statins in clinical practice: Are we using low doses of stains too often? AJM Braganza, G Eminowicz, SA Murphy, PM DiBattiste, GC Flaker, ... Journal of the American College of Cardiology 43 (5S1), A250-A250, 2004 | | 2004 |
| 1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial … AJ Kirtane, D Karmpaliotis, A Weisbord, A Bui, SA Murphy, D Budiu, ... Journal of the American College of Cardiology 43 (5S1), A262-A262, 2004 | | 2004 |
| 1060-83 Calcification of the culprit lesion is associated with adverse clinical outcomes in ST elevation myocardial infarction patients treated with fibrinolytic therapy D Karmpaliotis, AJ Kirtane, SA Murphy, I Kosmidou, D Budiu, D Guerra, ... Journal of the American College of Cardiology 43 (5S1), A261-A262, 2004 | | 2004 |
| 1097-94 Early versus delayed intervention in non-ST-elevation acute coronary syndromes: A natural experiment from the CRUSADE initiative JW Ryan, ED Peterson, A Chen, MT Roe, E Magnus Ohman, CP Cannon, ... Journal of the American College of Cardiology 43 (5S1), A276-A276, 2004 | | 2004 |
| 1097-97 Safety of stress testing following an acute coronary syndrome J Karha, CP Cannon, SA Murphy, PM DiBattiste, CM Gibson, E Braunwald Journal of the American College of Cardiology 43 (5S1), A277-A277, 2004 | 1 | 2004 |
| 1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes MS Sabatine, DA Morrow, RP Giugliano, SA Murphy, CH McCabe, ... Journal of the American College of Cardiology 43 (5S1), A278-A278, 2004 | | 2004 |
| 1118-82 Distinct modes of cardiovascular death associated with impaired epicardial and myocardial perfusion following fibrinolysis for ST elevation myocardial infarction SD Wiviott, MS Sabatine, DA Morrow, R Dumaine, SA Murphy, KE Boundy, ... Journal of the American College of Cardiology 43 (5S2), A290-A291, 2004 | | 2004 |
| 1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD) J Li, B Neal, HL Heerspink, C Arnott, C Cannon, R Agarwal, G Bakris, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 1141-198 Etoricoxib has no adverse effects on biomarkers of cardiovascular risk in patients with osteoarthritis PM DiBattiste, C Chen, J Viscusi, SP Curtis, CP Cannon Journal of the American College of Cardiology 43 (5S2), A511-A511, 2004 | 2 | 2004 |
| 117 Physicians Fail to Provide Protective Co-Therapy for High GI Risk Patients Taking NSAIDs—Even with Direct Interactive Communication and Free PPI: Results of a Prospective … L Laine, L Connors, MR Griffin, SP Curtis, CP Cannon Gastroenterology 4 (134), A-19, 2008 | 1 | 2008 |
| 129-LB: kidney and cardiovascular effects of canagliflozin according to age and sex in the CREDENCE trial TW Yi, B Smyth, A Kang, K Cardoza, GL Di Tanna, C Arnott, CA Pollock, ... Diabetes 70 (Suppleme), 2021 | 2 | 2021 |
| 133-LB: Canagliflozin Improves Cardiovascular and Renal Outcomes across Broad Geographic Regions: Results from CREDENCE K Cardoza, A Kang, B Smyth, TW Yi, GL Di Tanna, CA Pollock, ... Diabetes 70 (Suppleme), 2021 | | 2021 |
| 1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved … MN Kosiborod, SV Arnold, J Delemos, RS Rosenson, CM Ballantyne, ... Diabetes 69 (Supplement_1), 2020 | 1 | 2020 |
| 172-OR: Eligibility and Utilization of SGLT2i and GLP1-RA in T2D by Cardiovascular and Renal Indications A Blood, LS Chang, CA Colling, D Gabovitch, CM Hamersky, E Durden, ... Diabetes 71 (Supplement_1), 2022 | 2 | 2022 |
| 187 Influenza Vaccination and Reduction of Cardiovascular Events-A Systematic Review and Meta-Analysis JA Udell, ME Farkouh, DL Bhatt, CP Cannon Canadian Journal of Cardiology 5 (28), S161, 2012 | 10 | 2012 |
